SNX3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.338400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.787700E-02
Normal-vs-Stage2
9.086400E-02
Normal-vs-Stage3
1.091990E-01
Normal-vs-Stage4
3.224200E-01
Stage1-vs-Stage2
3.291200E-01
Stage1-vs-Stage3
7.014800E-01
Stage1-vs-Stage4
1.266440E-01
Stage2-vs-Stage3
7.493800E-01
Stage2-vs-Stage4
2.926800E-01
Stage3-vs-Stage4
2.469000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.068100E-02
Normal-vs-AfricanAmerican
3.174800E-01
Normal-vs-Asian
5.783700E-02
Caucasian-vs-AfricanAmerican
5.794400E-01
Caucasian-vs-Asian
2.453200E-01
AfricanAmerican-vs-Asian
3.093400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.276100E-02
Normal-vs-Female
1.093620E-01
Male-vs-Female
2.102600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.604300E-02
Normal-vs-Age(41-60Yrs)
1.711190E-01
Normal-vs-Age(61-80Yrs)
6.709900E-02
Normal-vs-Age(81-100Yrs)
5.400000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.069800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.878600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.415010E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.542070E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.358400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.475600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.810200E-02
Normal-vs-Daily Drinker
8.284700E-03
Normal-vs-Weekly Drinker
1.130770E-01
Normal-vs-Occasional Drinker
2.499600E-01
Normal-vs-Social Drinker
1.432610E-01
Non Drinker-vs-Daily Drinker
4.763200E-01
Non Drinker-vs-Weekly Drinker
5.602800E-01
Non Drinker-vs-Occasional Drinker
1.208830E-01
Non Drinker-vs-Social Drinker
4.903200E-01
Daily Drinker-vs-Weekly Drinker
2.091400E-01
Daily Drinker-vs-Occasional Drinker
2.356000E-02
Daily Drinker-vs-Social Drinker
1.768040E-01
Weekly Drinker-vs-Occasional Drinker
4.218600E-01
Weekly Drinker-vs-Social Drinker
9.273400E-01
Occasional Drinker-vs-Social Drinker
4.822000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.338800E-01
Normal-vs-Grade 2
8.358200E-01
Normal-vs-Grade 3
8.771400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.449600E-02
Grade 1-vs-Grade 3
3.776000E-01
Grade 1-vs-Grade 4
9.338800E-01
Grade 2-vs-Grade 3
3.773400E-01
Grade 2-vs-Grade 4
8.358200E-01
Grade 3-vs-Grade 4
8.771400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.299780E-01
Normal-vs-NonDiabetic
5.018100E-02
Diabetic-vs-NonDiabetic
4.823600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.943400E-03
Normal-vs-NoPancreatitis
9.130400E-02
Pancreatitis-vs-NoPancreatitis
3.341600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.644400E-02
Normal-vs-N1
9.646100E-02
N0-vs-N1
5.649400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.246500E-02
Normal-vs-TP53-NonMutant
8.947600E-02
TP53-Mutant-vs-TP53-NonMutant
7.194000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
